SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics for medical and non-medical applications, announced today that it is reassessing the exclusive Patent License Agreement with O2TODAY in light of O2TODAY’s decision to delay launch of its SiNPRO filters and masks.
On Thursday, O2TODAY shared that it has been made aware of regulatory requirements that prevent the distribution of its antiviral masks and filters and is refunding pre-orders. Given this new information, SINTX is considering a return to its initial joint development efforts with O2TODAY and revaluating all avenues of how it will bring the antipathogenic facemask technology to market.
The development and manufacture of antiviral face masks incorporated with SINTX silicon nitride is one component of SINTX’s broader business strategy of developing several antipathogenic fabric applications, including surgical gowns, drapes, scrub suits, and related products for medical personnel.
